Medicare Enrolled
Dr. Sanjivan Kohli, MD
Pulmonary Disease · San Juan Capistrano, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kohli from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kohli?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kohli
Dr. Sanjivan Kohli is a pulmonary disease specialist in San Juan Capistrano, CA, with 16 years of NPI registration. Based on federal Medicare data, Dr. Kohli performed 5,845 Medicare services across 2,217 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kohli received a total of $87,533 from 57 pharmaceutical and/or device companies across 479 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kohli is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice
▲ Top 4% volume in CA
$87,533 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,845
Medicare services
Top 4% in CA for pulmonary disease
2,217
Unique beneficiaries
$80
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~365 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Prolonged nursing facility care, each 15 minutes This code covers additional time spent by a physician or qualified professional in a nursing facility beyond the standard duration of the primary evaluation and management service. |
1,756 | $26 | $75 |
| Nursing facility visit, high complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves a high level of medical decision making and takes at least 45 minutes. |
718 | $130 | $341 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
613 | $102 | $248 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
446 | $178 | $646 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
376 | $151 | $364 |
| Prolonged office E/M service, first 15 minutes This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service. |
335 | $27 | $78 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
219 | $68 | $191 |
| Additional 30 minutes of critical care This code represents an additional 30 minutes of critical care services provided beyond the initial critical care time period. |
209 | $89 | $284 |
| Prolonged inpatient or observation care, each additional 15 minutes This code is used for prolonged hospital inpatient or observation care services that extend beyond the total time required for the primary evaluation and management service. It covers each additional 15-minute increment of time spent by the provider. |
145 | $26 | $75 |
| Initial nursing facility care, high complexity An initial visit by a healthcare provider to a patient in a nursing facility involving a high level of medical decision making, lasting at least 45 minutes. |
140 | $154 | $411 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
111 | $51 | $142 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
107 | $34 | $147 |
| Breathing device use evaluation An assessment of how a patient uses a breathing device. The provider reviews the patient's technique and device handling. |
96 | $16 | $46 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
75 | $93 | $262 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
74 | $40 | $110 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
72 | $146 | $438 |
| New patient office visit, complex (60-74 min) | 61 | $187 | $497 |
| Bronchial irrigation and suction for cell collection This procedure uses an endoscope to flush and suction the lung airways in order to collect cells for testing. |
43 | $19 | $744 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
37 | $48 | $140 |
| Overnight continuous oxygen level test This test measures oxygen levels in the blood continuously overnight using a device attached to the ear or finger. |
29 | $24 | $39 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
28 | $103 | $268 |
| Endoscopic needle biopsy of windpipe, airway, or lung A procedure where a needle is inserted through an endoscope to collect tissue samples from the windpipe, airway, or lung. |
26 | $97 | $792 |
| Lung biopsy via endoscope, 1 lobe A procedure to remove a small sample of lung tissue from one lobe using an endoscope for examination. |
23 | $39 | $960 |
| Bronchoscopy with ultrasound and lymph node sampling A procedure using a scope and ultrasound to examine the airways and collect tissue samples from three or more lymph nodes. |
20 | $190 | $1,989 |
| Ultrasound scan of chest An imaging test that uses sound waves to create pictures of the structures inside the chest. |
20 | $49 | $107 |
| Computer-assisted navigation of lung airways This procedure uses computer technology to guide an endoscope through the airways of the lungs for precise navigation. |
19 | $78 | $1,613 |
| Bronchoscopy with ultrasound and growth treatment A procedure using a flexible tube with a camera and ultrasound to examine the lung airways and treat any growths found. |
19 | $54 | $301 |
| Additional lung lobe biopsy via endoscope This procedure involves taking a tissue sample from an additional lobe of the lung using an endoscope. It is performed as an add-on service to a primary biopsy of a different lung lobe. |
17 | $51 | $202 |
| Additional lung lobe biopsy via endoscope This procedure involves taking a tissue sample from an additional lobe of the lung using an endoscope, performed after an initial biopsy. |
11 | $40 | $137 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$87,533
Total received (2018-2024)
Avg $12,505/year across 7 years
Top 4% in CA for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
57
Companies
479
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$59,622 (68.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$20,535 (23.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$7,375 (8.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$57,544
2023
$7,267
2022
$5,077
2021
$3,920
2020
$5,568
2019
$5,118
2018
$3,039
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
INTUITIVE SURGICAL, INC.
$50,426
Medical Device Business Services, Inc.
$2,482
Becton, Dickinson and Company
$1,375
Edwards Lifesciences Corporation
$1,200
Ethicon Inc.
$1,060
United Therapeutics Corporation
$234
Noah Medical Corporation
$103
SANOFI-AVENTIS U.S. LLC
$95
GENZYME CORPORATION
$78
Actelion Pharmaceuticals US, Inc.
$76
GlaxoSmithKline, LLC.
$57
AstraZeneca Pharmaceuticals LP
$56
Vifor Pharma, Inc.
$52
Takeda Pharmaceuticals U.S.A., Inc.
$48
Lilly USA, LLC
$45
Boehringer Ingelheim Pharmaceuticals, Inc.
$30
Merck Sharp & Dohme LLC
$26
Mylan Specialty L.P.
$25
Paratek Pharmaceuticals, Inc.
$24
Insmed, Inc.
$18
Janssen Pharmaceuticals, Inc
$18
ABBVIE INC.
$17
Top 3 companies account for 94.3% of 2024 payments
All-time payments by company (2018-2024) ›
INTUITIVE SURGICAL, INC.
$50,426
Edwards Lifesciences Corporation
$10,950
Intuitive Surgical, Inc.
$5,487
Ethicon Inc.
$4,812
Medical Device Business Services, Inc.
$3,542
Noah Medical Corporation
$1,608
Becton, Dickinson and Company
$1,375
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,116
GlaxoSmithKline, LLC.
$983
Boston Scientific Corporation
$890
GENZYME CORPORATION
$536
Grifols USA, LLC
$524
Takeda Pharmaceuticals U.S.A., Inc.
$501
Hill-Rom Services, Inc
$450
Genentech USA, Inc.
$445
Actelion Pharmaceuticals US, Inc.
$406
AstraZeneca Pharmaceuticals LP
$393
Philips Electronics North America Corporation
$314
Janssen Pharmaceuticals, Inc
$307
United Therapeutics Corporation
$277
Lilly USA, LLC
$194
Galvanize Therapeutics, Inc
$174
Mylan Specialty L.P.
$151
JAZZ PHARMACEUTICALS INC.
$135
Insmed, Inc.
$131
Electromed, Inc.
$118
Advanced Respiratory, Inc
$105
Baxter Healthcare
$105
Veran Medical Technologies, Inc.
$100
SANOFI-AVENTIS U.S. LLC
$95
ABBVIE INC.
$84
Harmony Biosciences LLC
$65
Pulmonx Corporation
$59
Sunovion Pharmaceuticals Inc.
$54
Amgen Inc.
$53
Vifor Pharma, Inc.
$52
Allergan Inc.
$44
Astellas Pharma US Inc
$38
Jazz Pharmaceuticals Inc.
$35
Covis Pharma GmBH
$32
Regeneron Healthcare Solutions, Inc.
$29
Mallinckrodt Hospital Products Inc.
$27
Merck Sharp & Dohme LLC
$26
Merck Sharp & Dohme Corporation
$26
Shire North American Group Inc
$25
Axsome Therapeutics, Inc.
$24
Paratek Pharmaceuticals, Inc.
$24
La Jolla Pharmaceutical Company
$23
Smith+Nephew, Inc.
$22
Biohaven Pharmaceutical Holding Company Ltd.
$22
ADVANCED RESPIRATORY, INC
$21
E.R. Squibb & Sons, L.L.C.
$18
Sanofi Pasteur Inc.
$17
Circassia Pharmaceuticals Inc
$16
Vertiflex, Inc.
$15
Novo Nordisk Inc
$13
Bayer HealthCare Pharmaceuticals Inc.
$13
Top 3 companies account for 76.4% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ACQUIRE · ACTHAR · ALIYA SYSTEM · ALLODERM · ALVESCO · ANORO · AVYCAZ · Adempas · Arikayce · BEVESPI AEROSPHERE · BREZTRI · BROVANA · COREDX · CUVITRU · DUPIXENT · Da Vinci Surgical System · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · Edwards SAPIEN 3 Transcatheter Heart Valve · Esbriet · FARXIGA · FASENRA · GALAXY · GIAPREZA · GLASSIA · HYQVIA · HemoSphere · HemoSphere advanced monitoring platform · Hillrom - Life 2000 Ventilation System · INVOKANA · JANUVIA · JARDIANCE · LONHALA MAGNAIR · Life2000 Ventilation System · MOUNJARO · Monarch · Monarch Platform · NO PRODUCT DISCUSSED · NUCALA · NURTEC ODT · NUZYRA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · PNEUMOVAX 23 · Prolastin-C · Prolastin-C Liquid · Pulmonx Endobronchial Valve EBV · RENASYS GO v2 HOME · Respiratoriy Care Undiv · S&RC Und · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Saxenda · Spin · Sunosi · Superion ISS · TEFLARO · TEZSPIRE · TRELEGY ELLIPTA · TRULICITY · TUDORZA PRESSAIR · TYVASO · The Swan-Ganz Catheter · The Vest System Model 105 Home Care · The VitalCough System · Trilogy 100 · ULTRAFLEX · UPTRAVI · VESICARE · WAKIX · WINREVAIR · Wakix · XARELTO · Xolair · Xyrem · YUPELRI · Yupelri · Zemaira · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (68%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pulmonary disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for pulmonary disease in CA.
Geographic Context
Pulmonary diseases within 10 mi
69
Per 100K population
2.2
County median income
$113,702
Nearest hospital
ALISO RIDGE BEHAVIORAL HEALTH, LLC
6.8 mi
6.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kohli is a mixed practice specialist, with above-average Medicare volume (top 4% in CA), with speaking/promotional industry engagement in the top 4% of CA peers, with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kohli experienced with prolonged nursing facility care, each 15 minutes?
Based on Medicare claims data, Dr. Kohli performed 1,756 prolonged nursing facility care, each 15 minutes services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kohli receive payments from pharmaceutical companies?
Yes. Dr. Kohli received a total of $87,533 from 57 companies across 479 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kohli's costs compare to other pulmonary diseases in San Juan Capistrano?
Dr. Kohli's average Medicare payment per service is $80. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kohli) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in San Juan Capistrano
Browse pulmonary diseases in San Juan Capistrano ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in CA
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in CA
Which CA pulmonary diseases receive the most from drug and device companies.
By company
INTUITIVE SURGICAL, INC. Payments to Doctors
See all physicians who received payments from INTUITIVE SURGICAL, INC.
By company
Edwards Lifesciences Corporation Payments to Doctors
See all physicians who received payments from Edwards Lifesciences Corporation.
By company
Intuitive Surgical, Inc. Payments to Doctors
See all physicians who received payments from Intuitive Surgical, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology